Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Target Lesion”

1,939 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,939 results

Not applicableEnded earlyNCT01177592
What this trial is testing

Thrombocyte Activity Reassessment and GEnoTyping for PCI(TARGET-PCI)

Who this might be right for
Coronary Artery Disease
LifeBridge Health 7
Not applicableStudy completedNCT00347217
What this trial is testing

Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event

Who this might be right for
Hypercholesteremia
AstraZeneca 3,840
Not applicableLooking for participantsNCT07818876
What this trial is testing

Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety: R33 Phase

Who this might be right for
Anxiety Disorders
University of Denver 72
Testing effectiveness (Phase 2)Looking for participantsNCT07462650
What this trial is testing

Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer MetastaticAdenocarcinoma of Colon
Beijing Biotech 48
Not applicableLooking for participantsNCT03476213
What this trial is testing

Manual Versus Targer-controll Infusion in Reduction of Awareness and Dreaming

Who this might be right for
Anesthesia Awareness
University Hospital Hradec Kralove 80
Testing effectiveness (Phase 2)Looking for participantsNCT07502287
What this trial is testing

Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma

Who this might be right for
Relapsed NeuroblastomaRefractory NeuroblastomaHigh-Risk Neuroblastoma+1 more
Beijing Biotech 36
Not applicableLooking for participantsNCT05049837
What this trial is testing

PROSPECT - Profiling of Resistance Patterns & Oncogenic Signaling Pathways in Evaluation of Cancers of the Thorax and Therapeutic Target Identification

Who this might be right for
Lung CancerCancer of Thorax
M.D. Anderson Cancer Center 7,200
Early research (Phase 1)Active Not RecruitingNCT02935257
What this trial is testing

Immunotherapy for High Risk/Relapsed CD19+ Acute Lymphoblastic Leukaemia, B-cell Non-Hodgkin's Lymphoma (B-NHL) and Chronic Lymphocytic Leukaemia (CLL)/ Small Lymphocytic Lymphoma (SLL) Using CAR T-cells to Target CD19

Who this might be right for
Leukemia, Lymphoblastic, Acute, Lymphoma
University College, London 72
Not applicableStudy completedNCT05229146
What this trial is testing

Improving Future Thinking Among Mothers to Reduce Harsh Parenting and Improve Child Outcomes

Who this might be right for
Behavioral Health
Henry Ford Health System 48
Not applicableEnded earlyNCT06937788
What this trial is testing

Replication of the Heads Up Atopic Dermatitis Trial With Registry Data

Who this might be right for
Atopic Dermatitis
Technische Universität Dresden 210
Post-approval studies (Phase 4)Study completedNCT01311141
What this trial is testing

Target Site Pharmacokinetics of Doripenem After a Single Dose of 500mg in Healthy Volunteers Dori_MD_1

Who this might be right for
Healthy
Medical University of Vienna 6
Not applicableStudy completedNCT06167941
What this trial is testing

Identification of Integrin ab Expression in Lung Cancer Patients

Who this might be right for
Expression of Integrin ανβ3 in Lung Cancer
Korea University Guro Hospital 61
Early research (Phase 1)Ended earlyNCT02060305
What this trial is testing

Intra-articular Bevacizumab for Recurrent Hemarthroses at Target Joints With Chronic Hemophilic Synovitis

Who this might be right for
HemophiliaSynovitis
National Taiwan University Hospital 5
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078305
What this trial is testing

Comparing the Combination of Trastuzumab and Regorafenib With Regorafenib Monotherapy for Advanced Hepatocellular Carcinoma After First-line Treatment

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 134
Large-scale testing (Phase 3)UnknownNCT03564470
What this trial is testing

Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL

Who this might be right for
LeukemiaLeukemia, AcuteLeukemia, Lymphoblastic+1 more
Nanfang Hospital, Southern Medical University 120
Not applicableStudy completedNCT02385942
What this trial is testing

KT(KT Corporation)-SNUBH(Seoul National University Bundang Hospital) U-health Cooperative Research

Who this might be right for
Pressure Ulcer
Chan-Yeong Heo 60
Not applicableStudy completedNCT04664595
What this trial is testing

Requirements of Propofol With Target Controlled Infusions for Supraglottic Airway Devices

Who this might be right for
Appropriate AffectComplication of Device Insertion
Prince of Songkla University 40
Not applicableStudy completedNCT04390477
What this trial is testing

Study to Evaluate the Effect of a Probiotic in COVID-19

Who this might be right for
COVID-19Coronavirus Infection
Bioithas SL 41
Not applicableEnded earlyNCT01101477
What this trial is testing

Target-Controlled Infusion of Propofol for Flexible Bronchoscopy Sedation

Who this might be right for
Flexible Bronchoscopy
Chang Gung Memorial Hospital 144
Not applicableStudy completedNCT03087175
What this trial is testing

MGuard Stent and Microcirculation

Who this might be right for
Coronary DiseaseCoronary Artery DiseaseCoronary Atherosclerosis+1 more
University Hospital, Grenoble 52
Next Page